Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

• Ngā kaituhi matua: Shinya Takasaki (Author), Hisanobu Adachi (Author), Yoshihide Kawasaki (Author), Masafumi Kikuchi (Author), Akihiro Ito (Author), Nariyasu Mano (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Pazopanib is an orally available multi-tyrosine kinase inhibitor and has been used to treat renal cell carcinoma (RCC). Here, we report the case of a patient with RCC with an increased prothrombin time-international normalized ratio (PT-INR) due to pazopanib therapy. In addition, we have reported th...